PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.6729
+0.0125 (1.89%)
Mar 6, 2026, 4:00 PM EST - Market closed
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $36.82 million as of March 6, 2026. Its market cap has decreased by -30.68% in one year.
Market Cap
36.82M
Enterprise Value
28.59M
1-Year Change
-30.68%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has decreased from $45.51M to $36.82M, a decrease of -19.10%. That is a compound annual growth rate of -2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 36.82M | -12.59% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xilio Therapeutics | 38.93M |
| Jasper Therapeutics | 38.62M |
| CervoMed | 38.03M |
| Sensei Biotherapeutics | 37.96M |
| Actinium Pharmaceuticals | 37.44M |
| Atara Biotherapeutics | 37.28M |
| Lisata Therapeutics | 36.87M |
| Tvardi Therapeutics | 36.87M |